Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion

Takashi Niizeki(Kurume University), Takuji Torimura(Omuta hospital), Masahito Nakano(Kurume University), Hironori Koga(Kurume University), Naoki Kamachi(Kurume University), Miwa Sakai(Kurume University), Shigeo Shimose(Kurume University), Hideki Iwamoto, Ryoko Kuromatsu(Kurume University), Hiroyuki Suzuki(Kurume University), Yu Noda(Kurume University), Shusuke Okamura(Kurume University), Tomotake Shirono(Kurume University)
Cancers
September 3, 2021
10.3390/cancers13174450
Cited by 25

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410